Studies defining the structure and function of MyBP-C in the sarcomere have shed light on the molecular mechanisms underlying the fine-tuning of muscle contraction and relaxation and on the processes and prognoses of cardiomyopathies and skeletal diseases induced by MYBPC gene mutations. The gene discussed is MYBPC2; the disease is bone disorder.